A prevascularized tissue engineering chamber supports growth and function of islets and progenitor cells in diabetic mice

Islets

Volumn 3, Issue 5, 2011, Pages 271-283

  Forster, Natasha A ^a   Penington, Anthony J ^a,b   Hardikar, Anandwardhan A ^a,b,c   Palmer, Jason A ^a   Hussey, Allan ^a   Tai, John ^a   Morrison, Wayne A ^a,b   Feeney, Sandra J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

Diabetes; Islet transplantation; Prevascularized chamber; Tissue engineering

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; GRAFT DYSFUNCTION; IMPLANTATION; IN VIVO CULTURE; INGUINAL REGION; MALE; MEDICAL RECORD; MOUSE; NONHUMAN; PANCREAS ISLET; STEM CELL; STEM CELL TRANSPLANTATION; STREPTOZOCIN DIABETES; TISSUE ENGINEERING; TISSUE GRAFT;

ANIMALS; BLOOD GLUCOSE; COLLAGEN; DELAYED GRAFT FUNCTION; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATIONS; EPIGASTRIC ARTERIES; GLUCOSE TOLERANCE TEST; GRAFT SURVIVAL; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LAMININ; MALE; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; SILICONES; STEM CELLS; TISSUE ENGINEERING;

EID: 80052777621     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.3.5.15942     Document Type: Article

References (42)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid- free immunosuppressive regimen. N Engl J Med 2000; 343:230-8; PMID:10911004; DOI:10.1056/NEJM200007273430401.
2. CITR Research Group. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant 2009; 18:753-67; PMID:19796497; DOI:10.3727/096368909X470874.
3. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9; PMID:15983207; DOI:10.2337/diabetes.54.7.2060.
4. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001; 50:489-95; PMID:11246867; DOI:10.2337/diabetes.50.3.489.
5. Zhang N, Qu S, Xu J, Bromberg JS, Dong HH. Inhibition of angiogenesis is associated with reduced islet engraftment in diabetic recipient mice. Transplant Proc 2005; 37:4452-7; PMID:16387144; DOI:10.1016/j.transproceed.2005.10.097.
6. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45:749-63; PMID:12107718; DOI:10.1007/s00125-002-0827-4.
7. Ichii H, Ricordi C. Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg 2009; 16:101-12; PMID:19110649; DOI:10.1007/s00534- 008-0021-2.
8. Phadnis SM, Joglekar MV, Dalvi MP, Muthyala S, Nair PD, Ghaskadbi SM, et al. Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo. Cytotherapy 2011; 13:279-93; PMID:21039304; DOI:10.3109/14653249.2010.523108.
9. Hardikar AA, Wang XY, Williams LJ, Kwok J, Wong R, Yao M, et al. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin. Endocrinology 2002; 143:3505-14; PMID:12193564; DOI:10.1210/en.2001-211344.
10. Kin T, Korbutt GS, Rajotte RV. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 2003; 3:281-5; PMID:12614282; DOI:10.1034/j.1600-6143.2003.00049.x.
11. Aoki T, Hui H, Umehara Y, LiCalzi S, Demetriou AA, Rozga J, et al. Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats. Cell Transplant 2005; 14:411-21; PMID:16180660; DOI:10.3727/000000005783982990.
12. Dufour JM, Rajotte RV, Zimmerman M, Rezania A, Kin T, Dixon DE, et al. Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng 2005; 11:1323-31; PMID:16259588; DOI:10.1089/ten.2005.11. 1323.
13. Chen X, Zhang X, Larson C, Chen F, Kissler H, Kaufman DB. The epididymal fat pad as a transplant site for minimal islet mass. Transplantation 2007; 84:122-5; PMID:17627248; DOI:10.1097/01.tp.0000266909.58117.e3.
14. Weber CJ, Hardy MA, Pi-Sunyer F, Zimmerman E, Reemtsma K. Tissue culture preservation and intramuscular transplantation of pancreatic islets. Surgery 1978; 84:166-74; PMID:149384.
15. Rafael E, Tibell A, Ryden M, Lundgren T, Savendahl L, Borgstrom B, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008; 8:458-62; PMID:18093267; DOI:10.1111/j.1600-6143.2007.02060.x.
16. Christoffersson G, Henriksnas J, Johansson L, Rolny C, Ahlstrom H, Caballero-Corbalan J, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 2010; 59:2569-78; PMID:20651296; DOI:10.2337/db10-0205.
17. Speier S, Nyqvist D, Cabrera O, Yu J, Molano RD, Pileggi A, et al. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 2008; 14:574-8; PMID:18327249; DOI:10.1038/nm1701.
18. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 1996; 61:1557-61; PMID:8669096; DOI:10.1097/00007890-199606150-00001.
19. Kawakami Y, Iwata H, Gu Y, Miyamoto M, Murakami Y, Yamasaki T, et al. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation. Cell Transplant 2000; 9:729-32; PMID:11144974.
20. Sakurai T, Satake A, Nagata N, Gu Y, Hiura A, Doo-Hoon K, et al. The development of new immunoisolatory devices possessing the ability to induce neovascularization. Cell Transplant 2003; 12:527-35; PMID:12953927.
21. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006; 81:1318-24; PMID:16699461; DOI:10.1097/01.tp.0000203858.41105.88.
22. Hussey AJ, Winardi M, Han XL, Thomas GP, Penington AJ, Morrison WA, et al. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A 2009; 15:3823-33; PMID:19558221; DOI:10.1089/ten.tea.2008.0682.
23. Sakata N, Tan A, Chan N, Obenaus A, Mace J, Peverini R, et al. Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplant Proc 2009; 41:346-9; PMID:19249553; DOI:10.1016/j.transproceed.2008.08.155.
24. Marselli L, Thorne J, Ahn YB, Omer A, Sgroi DC, Libermann T, et al. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008; 93:1046-53; PMID:18073315; DOI:10.1210/jc.2007-0931.
25. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000; 97:7999-8004; PMID:10884429; DOI:10.1073/pnas.97.14.7999.
26. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004; 306:2261-4; PMID:15564314; DOI:10.1126/science.1101968.
27. Hardikar AA, Marcus-Samuels B, Geras-Raaka E, Raaka BM, Gershengorn MC. Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates. Proc Natl Acad Sci USA 2003; 100:7117-22; PMID:12799459; DOI:10.1073/pnas.1232230100.
28. Bogdani M, Lefebvre V, Buelens N, Bock T, Pipeleers-Marichal M, In't Veld P, et al. Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors. Diabetologia 2003; 46:830-8; PMID:12774167; DOI:10.1007/s00125-003-1118-4.
29. Castellarin ML, Petropavlovskaia M, Lipsett MA, Rosenberg L. The identification and sequence analysis of a new Reg3gamma and Reg2 in the Syrian golden hamster. Biochim Biophys Acta 2007; 1769:579-85.
30. Joglekar MV, Parekh VS, Mehta S, Bhonde RR, Hardikar AA. MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol 2007; 311:603-12; PMID:17936263; DOI:10.1016/j.ydbio.2007.09.008.
31. Kaneto H, Miyatsuka T, Shiraiwa T, Yamamoto K, Kato K, Fujitani Y, et al. Crucial role of PDX-1 in pancreas development, beta-cell differentiation and induction of surrogate beta-cells. Curr Med Chem 2007; 14:1745-52; PMID:17627512; DOI:10.2174/092986707781058887.
32. Menger MD, Jaeger S, Walter P, Feifel G, Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989; 38:199-201; PMID:2463196.
33. Meier J, Kohler C, Alkhatib B, Sergi C, Junker T, Klein H, et al. Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 2009.
34. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57:1584-94; PMID:18334605; DOI:10.2337/db07-1369.
35. Cabrera Vasquez S, Navarro-Tableros V, Sanchez-Soto C, Gutierrez-Ospina G, Hiriart M. Remodelling sympathetic innervation in rat pancreatic islets ontogeny. BMC Dev Biol 2009; 9:34; PMID:19534767; DOI:10.1186/1471-213X-9-34.
36. Tan M, Kandaswamy R, Sutherland DE, Gruessner RW, Gruessner AC, Humar A. Risk factors and impact of delayed graft function after pancreas transplants. Am J Transplant 2004; 4:758-62; PMID:15084171; DOI:10.1111/j.1600-6143.2004.00408. x.
37. Nghiem DD, Hsia S, Schlosser JD, Nghiem HG. Delayed endocrine graft function: truth or myth? Transplant Proc 1998; 30:284; PMID:9532040; DOI:10.1016/S0041-1345(97)01269-4.
38. Lo CY, Tam SC. Parathyroid autotransplantation during thyroidectomy: documentation of graft function. Arch Surg 2001; 136:1381-5; PMID:11735864; DOI:10.1001/archsurg.136.12.1381.
39. Cantarelli E, Melzi R, Mercalli A, Sordi V, Ferrari G, Lederer CW, et al. Bone marrow as an alternative site for islet transplantation. Blood 2009; 114:4566-74; PMID:19773545; DOI:10.1182/blood-2009-03-209973.
40. Nomikos I, Kalogerakos K, Athanasiou E, Plakokefalos E, Sioutopoulou D, Satra M, et al. Role of hyperglycemia in isogeneic islet transplantation: an experimental animal study. Exp Clin Endocrinol Diabetes 2008; 116:558-60; PMID:18473285; DOI:10.1055/s-2008-1062711.
41. Cronin KJ, Messina A, Knight KR, Cooper-White JJ, Stevens GW, Penington AJ, et al. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg 2004; 113:260-9; PMID:14707645; DOI:10.1097/01.PRS.0000095942.71618.9D.
42. Joglekar MV, Patil D, Joglekar VM, Rao GV, Reddy DN, Mitnala S, et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 2009; 1:137-47; PMID:21099261; DOI:10.4161/isl.1.2.9578.